Skip to main content

Competence confirmed: SpiraTec is reseller partner for SIEMENS Opcenter Execution Pharma licenses

  • 16.10.2023

Wunstorf, October 16, 2023: SpiraTec consolidates its successful and long-standing partnership with SIEMENS AG and is now a reseller partner for SIEMENS Opcenter Execution Pharma licenses. SpiraTec thus belongs to an exclusive circle of reseller partners for Opcenter Pharma. Heiko Kröber, SIEMENS Partner Manager of the SpiraTec Group, is therefore particularly pleased: “The fact that we have achieved this status and can count ourselves among the few Opcenter Pharma partners is a great confirmation and underlines our competence as an MES solution partner for the pharmaceutical industry.”

Opcenter Execution Pharma is a digital platform that seamlessly integrates MES functionality, automation and enterprise resource planning (ERP) systems. It enables the streamlining of processes and workflows in full compliance with all regulations thanks to completely paperless production and end-to-end electronic batch reporting for the pharmaceutical industry.

Thanks to the new partner status, SpiraTec is now able to offer the implementation of MES projects based on SIEMENS Opcenter Execution Pharma completely and independently. Customers receive the complete service and do not have to purchase the license from Siemens themselves. Heiko Kröber emphasizes: “The conclusion of the reseller agreement is the result of our continuous development as a Siemens MES partner. This benefits our customers in the pharmaceutical industry, who we can now advise and support even more comprehensively.”
In the pharmaceutical sector, the MES partnership between Siemens and SpiraTec has existed since 2004 – initially for SIMATIC IT, followed by SIMATIC IT eBR, which was merged into Opcenter Pharma. Since then, SpiraTec has successfully cooperated with SIEMENS as a partner in a wide variety of projects. In addition, SpiraTec is always actively involved, such as at the SIEMENS Pharma User Forum 2023 in Toulouse, where projects, applications, developments and strategies in the pharmaceutical ecosystem between Siemens, pharmaceutical companies and Siemens partners were presented and discussed.